Indication
Skin Disorders
1 clinical trial
1 product
Clinical trial
A Phase I/II, Open-Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects for Cutaneous PhotoagingStatus: Active (not recruiting), Estimated PCD: 2024-04-30